Attention IASLC Voting Members!!

Check your email for "Your Vote Matters: Cast Your Ballot on IASLC Bylaws Today" OR cast your ballot here: https://app.propfuel.com/checkin/embed/0134a829-044f-4013-9a86-9673a398e121

Best Practice for RET NSCLC

Episode
205
Soundcloud
Share

Host Dr. Stephen Liu moderates a discussion on RET as a therapeutic target in this episode of Lung Cancer Considered. RET fusions are a known actionable alteration, and this field has blossomed very quickly. He is joined on the podcast by Dr. Oliver Gautschi from the University of Bern and Cancer Center Lucerne in Switzerland and Dr. Mihaela Aldea from Gustave Roussy in France.

Guest
Stephen Liu
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Mihaela Aldea
Mihaela Aldea

MD, PhD

Thoracic Oncology and Precision Medicine Group Department of Medical Oncology
Gustave Roussy, Villejuif, France
Oliver Gautschi
Oliver Gautschi

MD

Professor of Oncology and Head of Clinical Trial Unit
Cancer Center Lucerne, Switzerland

Other Podcast

Phase III CheckMate 77T Study
Episode
269
FDA Approval: TTFields for NSCLC
Episode
268
ESMO Asia 2024 Highlights
Episode
267